PVLAPalvella Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 20511
Ticker: PVLA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-12-16
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: PVLA

Detail

Enriched 2026-08-14 20:47

Market cap: $2,234,249,645.49
Shares outstanding (class): 14,408,407
Shares outstanding (weighted): 14,408,007
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 29
Location: WAYNE, PA
Homepage: https://www.palvellatx.com
Description: Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Market cap and share counts drift.

Funds holding this security

94 funds · 99 positions · $257.91M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$45.08M	0.00%	361,690 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$34.18M	0.46%	274,232 NS	FIGI
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$28.85M	1.82%	231,484 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$23.62M	0.03%	189,480 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$19.09M	0.18%	153,120 NS	FIGI
Artisan International Small-Mid Fund Artisan Partners Funds Inc.	—	$15.03M	0.56%	120,586 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$12.90M	0.02%	103,470 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$10.21M	0.08%	81,883 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$7.37M	0.06%	59,134 NS	FIGI
abrdn Healthcare Investors —	—	$6.83M	0.60%	54,759 NS	FIGI
PGIM Jennison Small Company Fund Prudential Jennison Small Co Fund, Inc.	—	$6.64M	0.21%	53,271 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$5.82M	0.07%	46,729 NS	FIGI
abrdn Life Sciences Investors —	—	$3.28M	0.59%	26,322 NS	FIGI
Small Cap Core Portfolio Bernstein Fund Inc	—	$2.69M	0.38%	21,576 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$2.65M	0.26%	21,246 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERPVLA
FIGI_COMPOSITEBBG0055C3N57
FIGI_SHARE_CLASSBBG0055C3N66
CIK0001583648
ISINUS6979471090
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals per SIC 2834.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.